{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:50Z","timestamp":1792686230426,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijcha.2025.101745","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:08:17Z","timestamp":1752599297000},"page":"101745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients"],"prefix":"10.1016","volume":"59","author":[{"given":"Akihiro","family":"Sunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirota","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhisa","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Egami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Minamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungo","family":"Hikoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sotomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijcha.2025.101745_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"19","key":"10.1016\/j.ijcha.2025.101745_b0010","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","article-title":"Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020","volume":"106","author":"Ding","year":"2020","journal-title":"Heart"},{"issue":"9658","key":"10.1016\/j.ijcha.2025.101745_b0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101745_b0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/europace\/euz257","article-title":"Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey","volume":"22","author":"Farkowski","year":"2020","journal-title":"Europace"},{"issue":"23","key":"10.1016\/j.ijcha.2025.101745_b0025","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.jacc.2021.04.036","article-title":"Prevalence of Left Atrial Thrombus inAnticoagulated patients with AtrialFibrillation","volume":"77","author":"Lurie","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101745_b0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101745_b0035","first-page":"252","article-title":"Assessment and Management of the Left Atrial Appendage Thrombus in patients with Nonvalvular Atrial Fibrillation","volume":"34","author":"Zhan","year":"2018","journal-title":"Can. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101745_b0040","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.amjcard.2017.06.022","article-title":"Outcomes for Atrial Fibrillation patients with Silent Left Atrial Thrombi Detected by Transesophageal Echocardiography","volume":"120","author":"Inoue","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101745_b0045","doi-asserted-by":"crossref","unstructured":"Okada M, Inoue K, Tanaka N, et al. Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study. Europace. May 2 2024;26(5)doi:10.1093\/europace\/euae120.","DOI":"10.1093\/europace\/euae120"},{"issue":"9","key":"10.1016\/j.ijcha.2025.101745_b0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1253\/circrep.CR-20-0036","article-title":"Comparison of Long-Term Outcomes between Combination Antiplatelet and Anticoagulant Therapy and Anticoagulant Monotherapy in patients with Atrial Fibrillation and Left Atrial Thrombi","volume":"2","author":"Sunaga","year":"2020","journal-title":"Circ Rep."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101745_b0055","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ijcha.2025.101745_b0060","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101745_b0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijcha.2025.101745_b0070","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101745_b0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.ijcha.2025.101745_b0080","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ijcha.2025.101745_b0085","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6 Pt 1","key":"10.1016\/j.ijcha.2025.101745_b0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8175.1997.tb00768.x","article-title":"Age-Dependent Prevalence of Cardioembolic sources Detected by TEE: Diagnostic and Therapeutic Implications","volume":"14","author":"Buser","year":"1997","journal-title":"Echocardiography"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101745_b0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCIMAGING.112.000153","article-title":"Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis","volume":"6","author":"Romero","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"6","key":"10.1016\/j.ijcha.2025.101745_b0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/joa3.12714","article-title":"JCS\/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias","volume":"38","author":"Ono","year":"2022","journal-title":"J Arrhythm."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101745_b0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2025.101745_b0110","doi-asserted-by":"crossref","unstructured":"Anic A, Bakovic D, Jurisic Z, et al. Diagnostic and therapeutic pathways for the malignant left atrial appendage: European Heart Rhythm Association physician survey. Europace. Jul 4 2023;25(7)doi:10.1093\/europace\/euad204.","DOI":"10.1093\/europace\/euad204"},{"issue":"6","key":"10.1016\/j.ijcha.2025.101745_b0115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jacc.2016.11.045","article-title":"Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: an Academic Research Consortium Initiative","volume":"69","author":"Lansky","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101745_b0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2025.101745_b0125","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"Bmj. Jan 31"},{"key":"10.1016\/j.ijcha.2025.101745_b0130","doi-asserted-by":"crossref","unstructured":"Faggiano P, Dinatolo E, Moreo A, et al. Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study. J Clin Med. Mar 10 2022;11(6)doi:10.3390\/jcm11061520.","DOI":"10.3390\/jcm11061520"},{"key":"10.1016\/j.ijcha.2025.101745_b0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101745_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjcard.2018.09.027","article-title":"Prevalence and Resolution of Left Atrial Thrombus in patients with Nonvalvular Atrial Fibrillation and Flutter with Oral Anticoagulation","volume":"123","author":"Niku","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101745_b0145","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/pace.13368","article-title":"Oral anticoagulation and left atrial thrombi resolution in nonrheumatic atrial fibrillation or flutter: a systematic review and meta-analysis","volume":"41","author":"Wang","year":"2018","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcha.2025.101745_b0150","doi-asserted-by":"crossref","unstructured":"Cheng YY, Tan S, Hong CT, Yang CC, Chan L. Left Atrial Appendage Thrombosis and Oral Anticoagulants: A Meta-Analysis of Risk and Treatment Response. J Cardiovasc Dev Dis. Oct 13 2022;9(10)doi:10.3390\/jcdd9100351.","DOI":"10.3390\/jcdd9100351"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:05:57Z","timestamp":1755619557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S2352906725001484"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101745","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101745"}}